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On 6 August 2009, a paper has been published in the New
England Journal of Medicine, which claims to prove that
vertebroplasty is not effective [1]. This paper has drawn an
attention worldwide, which is only rarely given to issues of
musculoskeletal system medicine. The New York Times
and almost all major international dailies have reported this
work. Dr. Buchbinder, the Australian main author of the
mentioned paper has been cited in the New York Times
from 7 August 2009 with the strong sentence ‘‘that she
would never undergo such an intervention’’. This is like a
religious confession, and I do not get rid of the suspicion
that this confession was there before the study, and the
presented work has now proven it.
It would be more interesting at this point to learn how
the advocates against vertebroplasty would deal with the
often extreme vertebral pain and possible progressive
kyphosis if the patient does not want to be just knocked out
by morphine medication and also has some demands of a
reasonable quality of life.
The incidence of vertebral compression fractures per
year is about 1.4 million people, and more than half of them
are found in the US of whom only about one-third is treated
[2]. With the increasing aging of the population, these
figures will increase in spite of prophylaxis. The true
prevalence of those fractures, however, is unknown because
these fractures are differently defined and also assessed. The
yearly direct medical costs for the treatment of those
fractures in the US are estimated to be between 12 and 18
billion US$ for the year 2002 [2]. In the last 6 years, the
number of the vertebroplasties in the US has doubled and is
done in 4.3–8.9 patients per 1,000 people [2]. Even higher
figures may apply for Europe. In spite of several studies,
which have shown a positive effect of vertebroplasty [3, 4],
there has never been done a blinded or a placebo controlled
randomized study to prove this postulated effect in a clean
scientific way [2]. However, this kind of studies is generally
speaking difficult to achieve in surgical procedures and
often reaches the limit of ethically acceptable studies.
Now, the paper has arrived, for which all intervention-
ists with a commitment to evidence have waited for—
however, big disappointment has spread out since this
paper does not hold what it promised and what the publi-
cation in the highly prestigious New England Journal of
Medicine would have made expect. A few quite essential
questions arise about the validity of this paper, since the
topic of it is of major practical significance.
This study is based on totally 78 patients who have been
selected from a pool of potential 468 patients (!). 38
patients have been treated with a vertebroplasty, the others
with a sham procedure including local anesthesia to the
facet joints. This means that, in an average, 9.5 cases per
center distributed over a time period of 54 months have
been treated with a vertebroplasty, i.e. there were less than
0.73 vertebroplasties done per month and per center. If we
consider only the 3 out of 4 centers, which contributed less
than 10 cases or even only 5 cases for the study, then even
less patients have been treated with vertebroplasty: 1 case
every 2 years or even less—this can really not be consid-
ered as examples for expert centers. Only these little
numbers distributed over a time interval of 54 months and
4 unequal centers are questionable in terms of methodology
and make this study untrustworthy.
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There is an additional problem, which has been brought
up by the authors who wrote themselves on page 565:
‘‘However, selection bias cannot be entirely ruled out,
since 30% of potentially eligible patients declined to
participate in the study.’’
But it comes even better: the relevant inclusion criteria
qualifying for this study is back pain for less than
12 months, the type of back pain, however, is not clearly
defined. There are obviously different kinds of back pain,
specifically back pain which goes along with a mechanical
instability or pain under mechanical load. Consequently,
there are quite different, pretty precise criteria for the
indication of a vertebroplasty: besides the typical pain
pattern, it needs to be taken in consideration mechanical
criteria of increasing kyphosis of a vertebra or vertebral
section and certain morphotypes of fractures. It is also well
known that an increasing kyphosis due to serial fractures
can finally increase the mortality because of pulmonary and
abdominal dysfunctions. Nothing of that has been men-
tioned in this paper or has been taken in consideration. In
addition, not all fractures can be put in the same pot.
Specifically, fractures of one, two, or more vertebra cannot
be considered as the same pathology. These are all
elements, which influence themselves unfavorably (con-
founding factors). Furthermore, the authors claim that the
executing radiologists (how many for how many cases
where they?) followed a strict standardized protocol,
however, whether this protocol really corresponds to what
experienced vertebroplasty surgeons do, is nowhere writ-
ten. From the amount of injected cement (2.8 ± 1.2 ml), it
can easily be concluded that the authors have done in
principle two placebo operations, and compared them with
each other (an insufficient vertebroplasty compared to a
facet bloc with local anesthesia in the control group) and
therefore the insignificant differences in terms of pain relief
and disability in both groups can be easily explained. Three
months postoperatively, the pain score for the vertebropl-
asty group was only 2.6, for the control group 1.9,
respectively, improved, what is fundamentally different
from all what has been published until today in several
studies [3, 4]. In addition, the follow-up of 1 year is short
to catch consequences of osteoporotic compression frac-
tures with increasing kyphosis, which finally may lead to
death.
This study is based on the above analysis, and is not in a
position to provide a new insight in to the relevance of
vertebroplasty in the treatment of osteoporotic vertebral
compression fractures, but contributes to a further irrita-
tion, by not helping at all the patients to make an informed
decision, or the doctors and insurances to make evidence-
based decisions. Although this study has been initiated by
serious and legitimated scientific questions, it remains
finally an artificial construct of desk writers, who are far
away from the clinical reality. Such studies are of no use
for the patients, or for the treating doctors. It would have
been much more reasonable to go at least one step down in
the ‘‘evidence pyramid’’ and to initiate a big prospective
national observational study in form of a registry, which
pictures the reality of the medical routine, and which
includes relevant outcome parameters. Such registries can
even be organized in an international network, and can
therefore establish generally valid benchmarks. However,
those registries should be under the mandate of the pro-
fessional societies, which are also in a position to make an
audit of the data in different institutions, which are inclu-
ded in those registries. This would certainly contribute to
an as big as possible transparency for the doctors and
patients. In this way, a big number of cases can be col-
lected, and therefore even with the different subgroups,
statistically significant conclusions can be made and con-
tribute to set treatment standards and guidelines [5]. Such a
procedure would certainly help the health services of dif-
ferent countries in a better way than artificial studies with
not adequate methodology, objectively wrong questions,
and treatment indications through questionably qualified
specialists in a small group of patients of unequal multi-
center groups during a far too long time period.
Sometimes, we cannot get rid of the impression that
prestigious scientific journals occasionally tend to sell an
ideology rather than to serve with objective science the sick
human beings.
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